| Next 10 |
ACCESSWIRE News Releases and Press Releases
ACCESSWIRE news releases, related news releases, and press releases on the OTC, NASDAQ and NYSE markets.
-
NEW YORK, NY / ACCESSWIRE / ACCESSWIRE / August 3, 2021 / AdvanceTC Ltd (NSX:A88)(OTCQB:ATCLF) (‘AdvanceTC' or the ‘Company') is pleased to announce that the Company, in recognition of its technologies, has established an R&D collaboration with The National University of Ma...
-
LITTLETON, CO / ACCESSWIRE / August 3, 2021 / Ur-Energy Inc. (NYSE American:URG)(TSX:URE) (the "Company" or "Ur-Energy") has filed the Company's Form 10-Q for the quarter ended June 30, 2021, with the U.S. Securities and Exchange Commission at www.sec.gov/edgar.shtml and with Canadian se...
-
TORONTO, ON / ACCESSWIRE / August 3, 2021 Electrovaya Inc. (TSX:EFL)(OTCQB:EFLVF) today announced that it will release the financial results for the quarter ended June 30, 2021 on Monday August 9th, 2021 after the markets close. CEO Dr. Sankar Das Gupta and EVP & CFO Richard Halka will h...
-
LOUISVILLE, KY / ACCESSWIRE / August 3, 2021 / Charah Solutions, Inc. (NYSE:CHRA) (together with its subsidiaries, "Charah Solutions" or the "Company"), a leading provider of environmental services and byproduct sales to the power generation industry, announced today that it will conduct a c...
-
AIDP to Sell RiceBran's SRB and SRB Derivative Ingredients to Supplement and Nutraceutical Market THE WOODLANDS, TX / ACCESSWIRE / August 3, 2021 / RiceBran Technologies (NASDAQ:RIBT), a global leader in the development and production of critical nutritional and functional ingredients...
-
COLORADO SPRINGS, CO / ACCESSWIRE / August 3, 2021 / Fortitude Gold Corp. (OTCQB:FTCO) (the "Company") reported record production and financial results for the second quarter ended June 30, 2021 of 14,579 ounces of gold produced at $628 per ounce all-in sustaining cost, $25.9 million net sal...
-
MCLEAN, VA / ACCESSWIRE / August 3, 2021 / Gladstone Capital Corporation (Nasdaq:GLAD) (the "Company") today announced earnings for its third fiscal quarter ended June 30, 2021. Please read the Company's Quarterly Report on Form 10-Q, filed today with the U.S. Securities and Exchange Commi...
-
GAINESVILLE, FL / ACCESSWIRE / August 3, 2021 / SharpSpring, Inc. (NASDAQ:SHSP), a leading cloud-based revenue growth platform, will issue its financial results on Thursday, August 12, 2018 at 4:05 p.m. Eastern time (1:05 p.m. Pacific time) for the second quarter ended June 30, 2021....
-
-Sales Increase 12.6% to $272.6 Million, the Fourth Consecutive Quarter of Double Digit Growth- -Operating Income Increases Over 22% to $24.7 Million; Operating Margin Expands to Over 9%- - Board Declares $0.16 Dividend - PORT WASHINGTON, NY / ACCESSWIRE / August 3, 2021 - Global...
-
LUXEMBOURG / ACCESSWIRE / August 3, 2021 / Ternium S.A. (NYSE:TX) today announced its results for the second quarter and first half ended June 30, 2021. The financial and operational information contained in this press release is based on Ternium S.A.'s operational data and consolidated co...
Now Trending
Trending Stock
25.41%Change Percent:
Applied DNA Sciences Inc Company Name:
APDN Stock Symbol:
NASDAQ Market:
adnas.com Website:
MENU
APDN Stock
APDN Quote
APDN Short
APDN News
APDN Articles
Get APDN Stock Alerts
News, Short Squeeze, Breakout and More Instantly...
RECENT APDN NEWS
-
- Full Service, Turnkey Solution Anchored by Applied DNA Clinical Labs’ safeCircle™ Pooled COVID-19 Testing to Be Deployed Across All 25 CUNY Campuses to Facilitate Fall Re-Opening – - Company to Report Fiscal Third Quarter Financial Results and Hold Inves...
-
Sustainability with Traceability Helps Secure Brands and Their Global Supply Chains Applied DNA Sciences, Inc. (NASDAQ: APDN), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and American & Efird, (A&E), the world’s foremost thread m...
-
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and its program development partner, Evvivax, S.R.L. (“Evvivax”), today announced results from an in vitro n...